|Day Low/High||1.52 / 1.57|
|52 Wk Low/High||0.66 / 2.75|
OPKO Health, Inc. (NASDAQ:OPK) and Transition Therapeutics Inc.
These stocks trading for less than $10 a share look poised to break out and trade higher from current levels.
Transition Therapeutics (TTHI) shares are rising after the company reported positive data from its Alzheimer treatment candidate.
These under-$10 stocks look poised to break out and trade higher from current levels.
The stock markets in the United Stated declined after gaining over the past two days. Today, the equity markets were negatively impacted by the slump in the shares of raw material and railroad compani...
These under-$10 stocks are within range of triggering major breakout trades.
These stocks are within range of triggering breakout trades.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Insiders at these companies have been scooping up shares of their own stock lately.
There's conviction behind the buying in these particular names, so they may be a good starting point.
LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Transition Therapeutics, Inc.
Transition Therapeutics (Nasdaq:TTHI) has been downgraded by TheStreet Ratings from from a hold to sell.
Shares of Transition Therapeutics (Nasdaq:TTHI) were gapping up Monday morning with an open price 25.7% higher than Friday's closing price. The stock closed at $4.01 yesterday and opened today's trading at $5.04.
Shares of Transition Therapeutics (Nasdaq:TTHI) have taken a tremendous swing upward. The stock is trading at $4.80 as of 9:42 a.m. ET, 34.5% above Friday's closing price of $3.57. Volume is at 244,416, 2.5 times the daily average of 96,800.
Transition Therapeutics (Nasdaq:TTHI) has been upgraded by TheStreet Ratings from a sell to hold.